Innovative Testing Technologies Arrayit Corporation specializes in proprietary life science technologies for disease prevention and treatment, such as allergy and COVID-19 testing platforms. There is an opportunity to promote advanced diagnostic solutions to healthcare providers seeking innovative, automated testing tools.

Market Expansion Potential Despite current revenue being under one million dollars, Arrayit's launch of a fully automated allergy testing portal indicates strong growth initiatives. Partnering to enhance or expand their testing services could capitalize on their push toward personalized medicine and streamlining diagnostics.

Regulatory and Compliance Needs Recent legal and securities-fraud issues pose risks but also highlight the importance of compliance solutions and secure, transparent processes. Offering regulatory consulting or secure data management products could address these vulnerabilities and build trust.

Research and Development Opportunities Arrayit's focus on discovering and developing proprietary technologies suggests ongoing R&D needs. Supplying research consumables, automation software, or laboratory equipment could strengthen their innovation pipeline.

Alignment with Biotech Leaders With competitors like Qiagen and Bio-Rad having large-scale operations, Arrayit's niche in personalized diagnostics presents an opportunity for tailored solutions that enhance efficiency, reduce costs, and differentiate their offerings in a competitive market.